Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:8249264.
doi: 10.1155/2017/8249264. Epub 2017 Aug 17.

The Effects of Vitamin D Supplement on Prevention of Recurrence of Preeclampsia in Pregnant Women with a History of Preeclampsia

Affiliations

The Effects of Vitamin D Supplement on Prevention of Recurrence of Preeclampsia in Pregnant Women with a History of Preeclampsia

Sanam Behjat Sasan et al. Obstet Gynecol Int. 2017.

Abstract

Introduction: Preeclampsia is a pregnancy-specific syndrome. One of the hypotheses concerning the etiology of preeclampsia is vitamin D deficiency during pregnancy.

Method and materials: The present study is a randomized controlled clinical trial which aims to determine the effect of vitamin D supplement on reducing the probability of recurrent preeclampsia. 72 patients were placed in control group while 70 patients were randomized to the intervention group. The intervention group received a 50000 IU pearl vitamin D3 once every two weeks. The control group was administered placebo. Vitamin D or placebo was given until the 36th week of pregnancy.

Results: The patients in intervention group have significantly lower (P value = 0.036) probability of preeclampsia than patients in the control group. The risk of preeclampsia for the control group was 1.94 times higher than that for the intervention group (95% CI 1.02, 3.71).

Conclusion: The intended intervention (i.e., prescription of vitamin D) has a protective effect against recurrent preeclampsia. Vitamin D supplementation therapy in pregnancy could help in reducing the incidence of gestational hypertension/preeclampsia.

Registration: This study has been registered in Iranian Registry of Clinical Trials (IRCT) site with ID number IRCT2017010131695N1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Williams J. W. williams Obstetrics. chapter 40, section 11-1 2014. Reproductive Tract Abnormalities.
    1. Steegers E. A., von Dadelszen P., Duvekot J. J., Pijnenborg R. Pre-eclampsia. The Lancet. 2010;376(9741):631–644. doi: 10.1016/S0140-6736(10)60279-6. - DOI - PubMed
    1. Shah D. M. Preeclampsia: new insights. Current Opinion in Nephrology and Hypertension. 2007;16(3):213–220. doi: 10.1097/MNH.0b013e3280d942e9. - DOI - PubMed
    1. Forman J. P., Giovannucci E., Holmes M. D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49(5):1063–1069. doi: 10.1161/HYPERTENSIONAHA.107.087288. - DOI - PubMed
    1. Hollis B. W., Johnson D., Hulsey T. C., Ebeling M., Wagner C. L. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. Journal of Bone and Mineral Research. 2011;26(10):2341–2357. doi: 10.1002/jbmr.463. - DOI - PMC - PubMed

LinkOut - more resources